Investing in the genome revolution, a bet on the future
More than 18 years ago, deciphering the sequence of human DNA cost 2.7 billion dollars and took more than 13 years of research.
Today, thanks to technological progress, greater globalization of the economy and new interests in the field of medicine, a genome sequence can be obtained for almost ten million times less money, which not only promotes investment in human genome research, but also opens opportunities for tailor-made medicine, a proposal that could eliminate genetic diseases, improve the quality of life of people worldwide and generate an attractive return for investors in technology.
Join us to learn some facts about investing in the genome revolution and its benefits.
Possibilities and benefits of genomics investment
The race for the most effective vaccine against COVID-19 has brought genomics to the forefront of technology investments for the future, raising more than $25 billion in investment for biotechnology research, such as genomics, in the first half of 2021 alone.
From mapping a person’s gene to modifying it, genomics encompasses many specific processes that require time, money and capable minds, so there is great diversity for investment in this area of scientific research.
Some studies focus on how to alter DNA using the revolutionary CRISPR scissors, which allow specific sequences of DNA structure to be changed at the cellular level, or how a change in the genetic sequence could lead to unanticipated changes, such as new DNA mutations.
The future of tailor-made medicine with genomics
But one of the most sought-after areas of genomics research is the complete elimination of genetic diseases, whether caused by mutations in the DNA sequence (such as Down’s syndrome) or hereditary tendencies (such as Alzheimer’s disease or some types of cancer).
It is precisely this area that could bring about a never-before-seen form of medical treatments: instead of designing strategies with medicines and/or ‘one-size-fits-all’ methods that work for the majority of the population, genomics will make it possible, through a detailed analysis of a person’s DNA, to know which options would be best for their case or, even, to create new treatment solutions from this information, tailored to them.